跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,337 条关于
“HDT Bio Corporation”
全部
9,337
临床试验
4,296
药物
1,445
机构
739
资讯
2,857
去年
FDA Clears HDT Bio's First-in-Class HDT-321 for Crimean-Congo Hemorrhagic Fever Prevention
2个月前
HDT Bio Launches Canadian Phase 1 Trial of HDT-401, a Locally Administered RNA Immune Activator for Glioblastoma
10个月前
Wheeler Bio Partners with Mitsubishi Corporation to Expand AI-Enabled Biomanufacturing Platform Across Asia-Pacific
去年
Phase 2 Trial Evaluates Host-Directed Therapies for Rifampicin-Resistant Tuberculosis
去年
Geron Corporation Advances in Myeloid Hematologic Malignancies Treatment
去年
Journey Medical's Emrosi Receives FDA Approval for Rosacea Treatment
去年
PDS Biotech Updates Phase 3 VERSATILE-003 Trial Design for HPV16-Positive HNSCC
去年
Genelux Advances Olvi-Vec Trials in Lung and Ovarian Cancer, Anticipates Key Data Readouts
3年前
Geron's Imetelstat Shows Promise in MDS and Myelofibrosis Trials, NDA Submission on Track
去年
PDS Biotech's VERSATILE-003 Phase 3 Trial for HPV16-Positive Head and Neck Cancer to Initiate Q1 2025
第 1 页,共 286 页
上一页
下一页